Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Dec 8;9(12):1027.
doi: 10.3390/pathogens9121027.

Mechanisms of Dysregulated Humoral and Cellular Immunity by SARS-CoV-2

Nima Taefehshokr  1 , Sina Taefehshokr  2 , Bryan Heit  1   3
Affiliations
Review

Mechanisms of Dysregulated Humoral and Cellular Immunity by SARS-CoV-2

Nima Taefehshokr et al. Pathogens. .

Abstract

The current coronavirus disease 2019 (COVID-19) pandemic, a disease caused by severe acute respiratory syndrome corona virus 2 (SARS-CoV-2), was first identified in December 2019 in China, and has led to thousands of mortalities globally each day. While the innate immune response serves as the first line of defense, viral clearance requires activation of adaptive immunity, which employs B and T cells to provide sanitizing immunity. SARS-CoV-2 has a potent arsenal of mechanisms used to counter this adaptive immune response through processes, such as T cells depletion and T cell exhaustion. These phenomena are most often observed in severe SARS-CoV-2 patients, pointing towards a link between T cell function and disease severity. Moreover, neutralizing antibody titers and memory B cell responses may be short lived in many SARS-CoV-2 patients, potentially exposing these patients to re-infection. In this review, we discuss our current understanding of B and T cells immune responses and activity in SARS-CoV-2 pathogenesis.

Keywords: B and T cell immune response; COVID-19; SARS-CoV-2; adaptive immunity.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

References

    1. Lu R., Zhao X., Li J., Niu P., Yang B., Wu H., Wang W., Song H., Huang B., Zhu N., et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: Implications for virus origins and receptor binding. Lancet. 2020;395:565–574. doi: 10.1016/S0140-6736(20)30251-8. - DOI - PMC - PubMed
    1. Chen G., Wu D., Guo W., Cao Y., Huang D., Wang H., Wang T., Zhang X., Chen H., Yu H., et al. Clinical and immunological features of severe and moderate coronavirus disease 2019. J. Clin. Investig. 2020;130:2620–2629. doi: 10.1172/JCI137244. - DOI - PMC - PubMed
    1. Adhikari S.P., Meng S., Wu Y.-J., Mao Y.-P., Ye R.-X., Wang Q.-Z., Sun C., Sylvia S., Rozelle S., Raat H., et al. Epidemiology, causes, clinical manifestation and diagnosis, prevention and control of coronavirus disease (COVID-19) during the early outbreak period: A scoping review. Infect. Dis. Poverty. 2020;9:29. doi: 10.1186/s40249-020-00646-x. - DOI - PMC - PubMed
    1. Koh D., Sng J. Lessons From the Past: Perspectives on Severe Acute Respiratory Syndrome. Asia Pac. J. Public Health. 2010;22:132S–136S. doi: 10.1177/1010539510373010. - DOI - PubMed
    1. Liu D.X., Liang J.Q., Fung T.S. Human Coronavirus-229E, -OC43, -NL63, and -HKU1. Ref. Module. Life Sci. 2020 doi: 10.1016/B978-0-12-809633-8.21501-X. - DOI

LinkOut - more resources